Quarterly report · Q1
9265.TEDINET S100RZJU
Period2023-06-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.0bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.5bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥196m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥259m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥213m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥274m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥268m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥281m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥162m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥165m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥160m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥163m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥22.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.0bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.8bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥63.53 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.7 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.2% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥268m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥73m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥73m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥7m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥13.9bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥13.9bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥455m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥17m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥17m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥1m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥14.0bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥14.0bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥464m |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥233m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥487m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥493m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 350
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to owners of parent | Prior1YTDDuration | 165000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 162000000 | JPY |
| Profit loss | Prior1YTDDuration | 163000000 | JPY |
| Profit loss | CurrentYTDDuration | 160000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 71000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 10000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 5000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 3000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 77000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 13000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 240000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 174000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 242000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 176000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -1000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -1000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 13383000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 71000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | 16000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 13471000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 13471000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 11000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 13395000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 71000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | 16000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 13483000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -11000000 | JPY |
| Net sales | Prior1YTDDuration | 13471000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 487000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 5000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | 0 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 493000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -233000000 | JPY |
| Operating income | Prior1YTDDuration | 259000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 13930000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 73000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | 17000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 14021000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 14021000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 0 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |